Navigation Links
Helix BioPharma Announces Q3 2009 Financial Results and Provides Product Development Update
Date:6/15/2009

pril 30, 2008: foreign exchange gains of $220,000 and $265,000, respectively). Foreign exchange losses for the three and nine month periods ended April 30, 2009 mainly reflect the lower Canadian dollar exchange rate relative to the US dollar with the largest impact affecting the most recent two quarters where the US dollar appreciated materially against all global currencies.

Income taxes

Income tax expense in the three and nine months ended April 30, 2009 totaled $29,000 and $83,000 respectively (three and nine month periods ended April 30, 2008: $27,000 and $89,000 respectively). All income taxes are attributable to the Company's operations in Ireland.

CASH FLOW

Operating activities

Cash used in operating activities in the three and nine month periods ended April 30, 2009 totaled $3,555,000 and $8,429,000, respectively (three and nine month periods ended April 30, 2008: $2,167,000 and $4,883,000 respectively). The increase in cash used in operating activities for the three and nine month periods ended April 30, 2009 compared to 2008, is mainly the result of higher research and development expenditures along with higher operating, general and administrative expenditures.

Financing activities

Financing activities in the three and nine month periods ended April 30, 2009 totaled $nil and $9,659,000 (three and nine month periods ended April 30, 2008: $nil and $14,614,000 respectively). All financing activities relate to two separate private placements in the given periods.

Investing activities

Use of cash in investing activities for the three and nine month periods ended April 30, 2009 totaled $416,000 and $490,000 (2008 - $42,000 and $101,000 respectively). All use of funds in investing activities represents capital acquisitions in the given periods.

LIQUIDITY, CAPITAL RESOURCES AND OUTLOOK

<
'/>"/>
SOURCE Helix BioPharma Corp.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Helix Biopharma announces addition of University of Arizona professor Kenneth Hatch as new medical advisor
2. Helix BioPharma Chairman resigns
3. Helix BioPharma Corp. announces fiscal 2007 results
4. Helix BioPharma Corp. announces management changes
5. Helix BioPharma announces $16.9 million private placement of common shares
6. Helix BioPharma announces Q1 2008 financial results
7. Helix BioPharma closes $16.9 million private placement of common shares
8. Helix BioPharma Corp. contracts KBI Biopharma to develop an L-DOS47 clinical packaging format
9. Helix BioPharma shareholders vote in favour of management
10. Helix BioPharma reports Q2 2008 highlights, financial results
11. W. Thomas Hodgson appointed to board of Helix BioPharma Corp.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)...  Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that the ... LLP Microcap Conference, May 30, in New York, ... , CPA, Chief Financial Officer of Cleveland BioLabs, will ... at 1:30 p.m. Eastern Time.  A live and archived webcast ... page of the Cleveland BioLabs website at www.cbiolabs.com . ...
(Date:5/22/2013)... 2013 Envera announced today that Michael ... Mr. McErlean has an extensive background in cell production ... his career. , Mike Matheny, President and ... have Mike join our team”. “Mike’s background is perfectly ... fermentation and downstream processing equipment”, added Matheny. “Mike’s ...
(Date:5/21/2013)... BEACH, Fla. , May 21, 2013 /PRNewswire/ ... FCN ), the global business advisory ... their enterprise value (the "Company"), announced that it ... personnel that were formerly included within the Corporate ... Litigation Consulting segment to form a single integrated ...
(Date:5/21/2013)... Alpha Source, Inc., a Wisconsin-based ... exhibiting for the 13th consecutive year at the ... 2013 Conference and Expo. The conference brings together ... healthcare technologies. This year’s event will be held ... , The three-day event draws over 1,500 healthcare ...
Breaking Biology Technology:Cleveland BioLabs to Present at Second Annual Marcum LLP Microcap Conference 2Envera Appoints Michael McErlean Fermentation Manager 2FTI Consulting Releases Realigned Segment Information Reflecting Newly Combined Health Solutions Practice 2Alpha Source, Inc. to Exhibit at the AAMI 2013 Conference and Expo 2
... BERLIN and CHICAGO , May 3, ... most important biotechnology segments in Germany .,With an estimated ... German diagnostics,market, the segment enjoys a compound annual growth rate ... toward personalized,medicine that are correspondingly increasing the market for molecular,diagnostics. ...
... ... on the products of newborn cells grown under embryonic conditions, will present new findings ... grown under Histogen,s proprietary conditions of hypoxia and low gravity show the expression of ... ...
... ... to improving the lives of others through their support of arts and culture, healthcare, education ... ... M.D. and his wife Michele B. Chan will be presented with the 10th KCET ...
Cached Biology Technology:BIO 2010: German Molecular Diagnostics Segment Posting Double-Digit Growth 2BIO 2010: German Molecular Diagnostics Segment Posting Double-Digit Growth 3Hypoxia Induces Stem Cell Gene Expression, Protein Production and Cell Surface Markers 2Hypoxia Induces Stem Cell Gene Expression, Protein Production and Cell Surface Markers 3Patrick Soon-Shiong, M.D. and Michele B. Chan Join Prestigious List of Recipients of KCET Visionary Award at 10th Gala Honoring Region's Philanthropic Leaders 2Patrick Soon-Shiong, M.D. and Michele B. Chan Join Prestigious List of Recipients of KCET Visionary Award at 10th Gala Honoring Region's Philanthropic Leaders 3Patrick Soon-Shiong, M.D. and Michele B. Chan Join Prestigious List of Recipients of KCET Visionary Award at 10th Gala Honoring Region's Philanthropic Leaders 4Patrick Soon-Shiong, M.D. and Michele B. Chan Join Prestigious List of Recipients of KCET Visionary Award at 10th Gala Honoring Region's Philanthropic Leaders 5
(Date:5/22/2013)... the biodiversity of pollinating insects and wild plants have ... , Researchers led by the University of Leeds and ... evidence of dramatic reductions in the diversity of species ... and 1980s. , But the picture brightened markedly after ... losses among bees, hoverflies and wild plants. ...
(Date:5/21/2013)... Biologists have known for a long time that ... isn,t well understood, particularly for plants. But it may ... of Australian National University and the U. S. National ... be published 21 May in the journal Nature ... have faster-changing genomes. , Drawing from a database of ...
(Date:5/21/2013)... increasingly being considered in the management of natural ... that can help them recognize and respond to ... their lives. , Place-Based Conservation: Perspectives from ... the Pacific Northwest Research Station,s Linda Kruger, can ... The book is published by Springer Verlag and ...
Breaking Biology News(10 mins):Encouraging signs for bee biodiversity 2Encouraging signs for bee biodiversity 3Small but speedy: Short plants live in the evolutionary fast lane 2
... Japanese villages of Taiji and Futo, a consortium of scientists ... to end the practices through public awareness and by appealing ... the hunts. The "Act for Dolphins" campaign--which includes members from ... of Zoos and Aquariums (WAZA) --maintains that the hunts, which ...
... Federale de Lausanne) have unveiled a new twist in ... against toxins made by disease-causing bacteria. , The discovery ... of the journal Cell, advances our understanding of how ... and parasites and also gives insight into the more ...
... that controls insulin responses has been shown to halt ... that the disease can be treated in its early ... Island Hospital and Brown Medical School. , Researchers ... several components of neurodegeneration and preserve learning and memory ...
Cached Biology News:Renewed dolphin slaughter prompts new campaign 2Renewed dolphin slaughter prompts new campaign 3A new understanding of how cells defend themselves against bacterial pore-forming toxins 2A new understanding of how cells defend themselves against bacterial pore-forming toxins 3Insulin receptor stops progression of Alzheimer's disease 2Insulin receptor stops progression of Alzheimer's disease 3